£100m secured for lung cancer trials

Achilles Therapeutics, a UK biotech co-founded by Professor Charles Swanton (UCL Cancer Institute), has secured £100m to further its research on personalised immunotherapy for cancer.

Read: FT, More: Telegraph (£)